
H2-receptor antagonists, melatonin, and thiamine are some of the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.

H2-receptor antagonists, melatonin, and thiamine are some of the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.

Vitamin C and zinc are among the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.

Published: June 22nd 2020 | Updated:

Published: June 23rd 2020 | Updated: